Literature DB >> 9545315

Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian homologues.

M Pohl1, S A Wank.   

Abstract

Helodermin and exendin-4, two peptides isolated from the salivary gland of the Gila monster, Heloderma suspectum, are approximately 50% homologous to vasoactive intestinal peptide (VIP) and glucagon-like peptide-1 (GLP-1), respectively, and interact with the mammalian receptors for VIP and GLP-1 with equal or higher affinity and efficacy. Immunohistochemical studies suggested the presence of helodermin-like peptides in mammals. To determine whether helodermin and exendin-4 are present in mammals and their evolutionary relationship to VIP and GLP-1, their cDNAs were first cloned from Gila monster salivary gland. Northern blots and reverse transcription-polymerase chain reaction of multiple Gila monster tissues identified approximately 500-base pair transcripts only from salivary gland. Both helodermin and exendin-4 full-length cDNAs were approximately 500 base pairs long, and they encoded precursor proteins containing the entire amino acid sequence of helodermin and exendin-4, as well as a 44- or 45-amino acid N-terminal extension peptide, respectively, having approximately 60% homology. The size and structural organization of these cDNAs indicated that they were closely related to one another but markedly different from known cDNAs for the VIP/GLP-1 peptide family previously identified in both lower and higher evolved species. Cloning of the Gila monster VIP/peptide histidine isoleucine, pituitary adenylate cyclase activating polypeptide, and glucagon/GLP-1 cDNAs and Southern blotting of Gila monster DNA demonstrate the coexistence of separate genes for these peptides and suggests, along with the restricted salivary gland expression, that helodermin and exendin-4 coevolved to serve a separate specialized function. Probing of a variety of rat and human tissues on Northern blots, human and rat Southern blots, and genomic and cDNA libraries with either helodermin- or exendin-4-specific cDNAs failed to identify evidence for mammalian homologues. These data indicate that helodermin and exendin-4 are not the precursors to VIP and GLP-1 and that they belong to a separate peptide family encoded by separate genes. Furthermore, the existence of as yet undiscovered mammalian homologues to helodermin and exendin-4 seems unlikely.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545315     DOI: 10.1074/jbc.273.16.9778

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates.

Authors:  Nicholas T Bello; Matthew H Kemm; Erica M Ofeldt; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-16       Impact factor: 3.619

2.  PKA-dependent activation of the vascular smooth muscle isoform of KATP channels by vasoactive intestinal polypeptide and its effect on relaxation of the mesenteric resistance artery.

Authors:  Yang Yang; Yun Shi; Shouli Guo; Shuang Zhang; Ningren Cui; Weiwei Shi; Daling Zhu; Chun Jiang
Journal:  Biochim Biophys Acta       Date:  2007-09-12

Review 3.  The role of gastrointestinal hormones in hepatic lipid metabolism.

Authors:  Jamie Eugene Mells; Frank A Anania
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

4.  Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice.

Authors:  Mitsuteru Akahoshi; Chang Ho Song; Adrian M Piliponsky; Martin Metz; Andrew Guzzetta; Magnus Abrink; Susan M Schlenner; Thorsten B Feyerabend; Hans-Reimer Rodewald; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

5.  Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.

Authors:  N-C Liang; N T Bello; T H Moran
Journal:  Int J Obes (Lond)       Date:  2012-02-07       Impact factor: 5.095

6.  Species-specific actions of incretin: from the evolutionary perspective.

Authors:  Yukiko Kawasaki; Yoshiyuki Hamamoto; Hiroyuki Koshiyama
Journal:  Jpn Clin Med       Date:  2010-10-19

7.  Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.

Authors:  David M Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.